Combining Gene Therapy with Chemotherapy

  • ChemPubSoc Europe Logo
  • Author: Angewandte Chemie International Edition
  • Published Date: 26 May 2019
  • Source / Publisher: Angewandte Chemie International Edition/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Combining Gene Therapy with Chemotherapy

Delivery of a drug and a gene in a single nanoparticle is of great interest for cancer therapy. Such systems could achieve a synergistic effect by combining chemotherapy and gene therapy. However, due to the drastically different physicochemical properties, it is difficult to encapsulate chemotherapeutics and nucleic acid therapeutics in a single nanoparticle.


Lele Li, National Center for Nanoscience and Technology, China, and colleagues have developed a simple approach to create nanoplatforms for the combined delivery of chemotherapeutic drugs and nucleic acid therapeutics. The team's system was synthesized through one-step coordination-driven self-assembly of two drugs together with iron(II) ions: the nucleic acid therapeutic G3139, which targets a protein that controls cell death, and the chemotherapy drug doxorubicin hydrochloride (DOX) (process pictured below).


The self-assembly was followed by mineralization of the assembly's surface with the metalā€organic framework (MOF) ZIF-8. For this, 2-methyl imidazole and zinc nitrate, the MOF's components, were added to a dispersion of the two-drug assembly and the reaction mixture was left standing for 24 hours.

The resulting core-shell nanoparticles have a well-defined spherical shape and a high drug-loading capacity. The ratio of the two therapeutic agents in the nanoparticles can be precisely adjusted. The system can efficiently accumulate in tumors and inhibit their growth. According to the researchers, this work provides a useful approach for the delivery of clinically used drug-gene combinations.

 


 

Article Views: 885

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH